Chi‐Ling Chen
Impact in
- Hepatology top 0.5%
- Hepatitis C virus research
- Hepatocellular Carcinoma Treatment and Prognosis
- Epidemiology top 0.5%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
- Adipokines, Inflammation, and Metabolic Diseases
Papers in
- Hepatology 32
- Hepatitis C virus research 21
- Hepatocellular Carcinoma Treatment and Prognosis 9
- Epidemiology 37
- Hepatitis B Virus Studies 23
- Adipokines, Inflammation, and Metabolic Diseases 8
- Liver Disease Diagnosis and Treatment 8
- Co-authors
- Pei‐Jer Chen (51 shared papers)Ding‐Shinn Chen (39 shared papers)Wei‐Shiung Yang (27 shared papers)Chun‐Jen Liu (47 shared papers)Jia‐Horng Kao (46 shared papers)Chen‐Hua Liu (35 shared papers)Tung‐Hung Su (31 shared papers)Tong‐Yuan Tai (6 shared papers)
- Journals
- PLoS ONE (8 papers)Hepatology (7 papers)Gastroenterology (5 papers)Alimentary Pharmacology & Therapeutics (5 papers)Medicine (4 papers)
- Partner nations
- TaiwanUnited StatesAustralia
In The Last Decade
Chi‐Ling Chen
124 papers receiving 6.9k citations
Chi‐Ling Chen's Hit Papers
Peers
Comparison fields: 5 of 140
- Hepatology 2.0k
- Epidemiology 3.7k
- Endocrine and Autonomic Systems 355
- Cancer Research 462
- Physiology 796
Countries citing papers authored by Chi‐Ling Chen
This map shows the geographic impact of Chi‐Ling Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Ling Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Ling Chen more than expected).
Fields of papers citing papers by Chi‐Ling Chen
This network shows the impact of papers produced by Chi‐Ling Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Ling Chen. The network helps show where Chi‐Ling Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Chi‐Ling Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 127 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Weight Reduction Increases Plasma Levels of an Adipose-Derived Anti-Inflammatory Protein, Adiponectin Hit paper breakdown → | 2001 | 1000 |
| 2 | High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load Hit paper breakdown → | 2012 | 474 |
| 3 | Metabolic Factors and Risk of Hepatocellular Carcinoma by Chronic Hepatitis B/C Infection: A Follow-up Study in Taiwan Hit paper breakdown → | 2008 | 460 |
| 4 | 2002 | 367 | |
| 5 | 2002 | 299 | |
| 6 | 2004 | 229 | |
| 7 | 2003 | 225 | |
| 8 | 2012 | 222 | |
| 9 | 2011 | 195 | |
| 10 | 2016 | 181 | |
| 11 | 2008 | 170 | |
| 12 | 2011 | 128 | |
| 13 | 2009 | 113 | |
| 14 | 2019 | 101 | |
| 15 | 2014 | 98 | |
| 16 | 2012 | 95 | |
| 17 | 2007 | 93 | |
| 18 | 2008 | 87 | |
| 19 | 2017 | 85 | |
| 20 | 2003 | 70 |
About Chi‐Ling Chen
Chi‐Ling Chen is a scholar working on Hepatology, Epidemiology, Obstetrics and Gynecology, Cancer Research and Cardiology and Cardiovascular Medicine, having authored 127 papers that have together received 7.1k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (23 papers), Hepatitis C virus research (21 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Adipokines, Inflammation, and Metabolic Diseases (8 papers), Liver Disease Diagnosis and Treatment (8 papers), Uterine Myomas and Treatments (4 papers), Arsenic contamination and mitigation (4 papers) and Cardiovascular Disease and Adiposity (3 papers). The work is most often cited by research in Hepatology (2.0k citations), Epidemiology (3.7k citations), Endocrine and Autonomic Systems (355 citations), Cancer Research (462 citations) and Physiology (796 citations). Chi‐Ling Chen has collaborated with scholars based in Taiwan, United States and Australia. Frequent co-authors include Pei‐Jer Chen, Ding‐Shinn Chen, Wei‐Shiung Yang, Chun‐Jen Liu, Jia‐Horng Kao, Chen‐Hua Liu, Tung‐Hung Su, Tong‐Yuan Tai, Tai‐Chung Tseng and Lee‐Ming Chuang. Their work appears in journals such as PLoS ONE, Hepatology, Gastroenterology, Alimentary Pharmacology & Therapeutics and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.